Andrew Left (Citron Research) Says Mallinckrodt is WORSE than Valeant

 

CNBC Video: Mr. Left vs. CEO Mark Trudeau of Mallinckrodt (11 minutes)

“I think Mallinckrodt is worse (than Valeant) because they are dependent on one drug, close to let’s say 50 percent of their EBITDA, depends on what metric you want to look at, is dependent on one particular drug. Not let’s say 30 that Valeant has,” said Left.

Financial Highlights:
Operating margin (%) 15.13
Net-margin (%) 13.05
P/E(ttm) 15.70
P/B 1.31

Video link: http://www.cnbc.com/…/short-seller-and-mallinckrodt-ceo-go-…

 

Join and see Pictures in https://www.facebook.com/groups/SeekingValue/

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s